Skip to Main Content

Paper Details

Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.
Clin Cancer Res
65
2016
ACC, ACC cell lines, ACC tumor, Adrenocortical Carcinoma, Adrenocortical carcinoma, BD140A, N-cadherin, NCI-H295R, Niclosamide, SW-13, cancer, caspase, cell lines, epithelial, mice, niclosamide, of -catenin, rare cancers, vimentin
Author NameAffiliation
Lisa ZhangNational Cancer Institute
Lisa ZhangNational Cancer Institute
Yaqin ZhangDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences
Yaqin ZhangDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences
Myriem BoufraqechNational Cancer Institute
Myriem BoufraqechNational Cancer Institute
Naris NilubolNational Cancer Institute
Naris NilubolNational Cancer Institute
Dhaval PatelNational Cancer Institute
Dhaval PatelNational Cancer Institute
Min ShenDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences
Min ShenDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences
Electron KebebewNational Cancer Institute
Electron KebebewNational Cancer Institute
  • 1 - 14

Datasets

Release 1.2